A Pilot Study of Salix SST (Saliva-stimulating Lozenges) in Post-irradiation Xerostomia
- 1 January 1998
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 14 (3) , 155-159
- https://doi.org/10.1185/03007999809113355
Abstract
Relief from the effects of radiation-induced xerostomia resulting from use of saliva-stimulating lozenges (Salix) has been subjectively evaluated. Ten patients took Salix as required for 7 days, and self-assessed using analogue scales before and after treatment. There was a marked and statistically significant improvement in the dryness and general comfort of the mouth, and beneficial effects on eating, sleeping and speech.Keywords
This publication has 4 references indexed in Scilit:
- Oral Pilocarpine for Post-Irradiation Xerostomia in Patients with Head and Neck CancerNew England Journal of Medicine, 1993
- Parotid gland function following accelerated and conventionally fractionated radiotherapyRadiotherapy and Oncology, 1991
- Effectiveness of pilocarpine in postradiation xerostomiaCancer, 1987
- Effect of Radiation-Induced Xerostomia on Human Oral MicrofloraJournal of Dental Research, 1975